Notice ID: b155cf9825c24837af8a45c01fc83aaaAward NoticeAwardedArchived
6505--Dimethyl Fumarate Capsules
Awarded on March 17, 2026. Full description on SAM.gov.
Awarded tounder 36E79726D0014 (source: SAM.gov award notice)• $10.4M
Overview
- Posted
- March 18, 2026
- Notice type
- Award Notice
- NAICS
- 325412: Pharmaceutical Preparation Manufacturing
- Agency
- Department of Veterans Affairs
Notice details
- Office
- NAC PHARMACEUTICALS (36E797)
- Last updated
- Nov 1, 2026
- First published
- Last updated on SAM.gov
- Award date
- Mar 17, 2026
- Award amount (SAM.gov award notice)
- $10.4M
Identifiers
- Solicitation number
- 36E79726R0003
- Notice ID
- b155cf9825c24837af8a45c01fc83aaa
- Award number (PIID)
- 36E79726D0014
Description
Amendment to extend solicitation due date to 12/9/2025 by 2:30 PM CST.
Award Overview
Award Number
36E79726D0014
Award Amount (SAM.gov award notice)
$10.4M
Award Date
Mar 17, 2026
Awardee
Awardee UEI
GQLDJJ8AQNN5
Awardee CAGE Code
1HT23
Awardee Address
CAMARILLO, CA 93012-8601, CA
Line Item Number
2
Original Solicitation
Notice ID: b155cf9825c24837af8a45c01fc83aaa
Posted Date: Mar 18, 2026
Original Response Deadline: Not specified
More From This Vendor
Top 5 most recent
- —Signed Nov 10, 2026
- —Signed Nov 10, 2026
- —Signed Nov 6, 2026
- —Signed Nov 6, 2026
- —Signed Nov 6, 2026
Contacts
Contracting Officer
Primary Contact
Documents
Files (1)
- Download
36E79726D0014_1.docx
13 KBAdded in Award Notice version 3Posted
Lifecycle
- 3Version 3Award NoticeArchivedCurrent
6505--Dimethyl Fumarate Capsules
Other notices for this solicitation
- Pre-SolicitationRelated noticeOct 22, 2025
6505--Dimethyl Fumarate Capsules
- SolicitationRelated noticeNov 19, 2025
6505--Dimethyl Fumarate Capsules
- SolicitationRelated noticeNov 20, 2025
6505--Dimethyl Fumarate Capsules
- SolicitationRelated noticeDec 2, 2025
6505--Dimethyl Fumarate Capsules
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Page 2 of 2 Page 2 of 2 PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79726R0034 for an unrestricted procurement for Ramipril capsules for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. Glass bottles are not acceptable. Solicitation # 36E79726R0034 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about 11/16/2026 with a tentative closing date of 11/30/2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Amber Zavala. Questions can be e-mailed to: amber.zavala@va.gov. The estimated annual requirements are as follows: Description Size Estimated Annual Requirements RAMIPRIL 1.25MG CAP 100/BT 2,930 RAMIPRIL 2.5MG CAP 100/BT 2,498 RAMIPRIL 2.5MG CAP 500/BT 1,611 RAMIPRIL 5MG CAP 100/BT 6,018 RAMIPRIL 5MG CAP 500/BT 2,704 RAMIPRIL 10MG CAP 100/BT 15,956 RAMIPRIL 10MG CAP 500/BT 4,451 | 95% | Pre-Solicitation | 11/23/2026 |
95% | Solicitation | 09/16/2026 | |
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79726R0033 for an unrestricted procurement for Tacrolimus Capsules, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. Solicitation #36E79726R0033 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about August 31, 2026, with a tentative closing date of September 15, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Chris Carthron. Questions can be e-mailed to Christopher.Carthron@va.gov. The estimated annual requirements are as follows: REQUIREMENT DESCRIPTION ITEM DESCRIPTION PACKAGE SIZE (Bottles) TOTAL ESTIMATED ANNUAL USAGE (Bottles) 1 TACROLIMUS 0.5MG CAP 100 51,904 2 TACROLIMUS 1MG CAP 100 142,788 3 TACROLIMUS 5MG CAP 100 5,207 | 95% | Pre-Solicitation | Open |
90% | Awarded | Open | |
87% | Awarded | Open |
Additional Details
Solicitation Number
36E79726R0003
Archive Date
May 17, 2026
Office Address
HINES, IL, 60141